Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Computational Network Analysis of Two Popular Skin Cancers Provides Insights into the Molecular Mechanisms and Reveals Common Therapeutic Targets
Md Abdullah Al Mahmud, Bikash Kumar Paul, Md Rakibul Hasan, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41688-e41688
Open Access
Gene expression profiling to uncover prognostic and therapeutic targets in colon cancer, combined with docking and dynamics studies to discover potent anticancer inhibitor
Mohammad Kashif
Computational Biology and Chemistry (2025) Vol. 115, pp. 108349-108349
Closed Access
GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells
Fumiya Ito, Wakiko Iwata, Yoshihiro Adachi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Two Cysteines in Raf Kinase Inhibitor Protein Make Differential Contributions to Structural Dynamics In Vitro
Hyun Sang Cho, Mohammad Faysal Al Mazid, Eun‐Young Lee, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 384-384
Open Access
New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108182-108182
Closed Access
Inhibition of Kinase Activity and In Vitro Downregulation of the Protein Kinases in Lung Cancer and Cervical Cancer Cell Lines and the Identified Known Anticancer Compounds of Ziziphus mucronata
Themba Sambo, Emelinah Mathe, Jerry L. Shai, et al.
Plants (2025) Vol. 14, Iss. 3, pp. 395-395
Open Access
Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing
Ziyi Wang, Li Gao, Ziheng Jia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
The interplay between gut bacteria and targeted therapies: implications for future cancer treatments
Juan He, Yu Chen, Huakan Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Tyrosine Kinase Inhibitor Lenvatinib Based Nano Formulations and Cutting-Edge Scale-Up Technologies in revolutionizing Cancer Therapy
Samia Shaikh, Padakanti Sandeep Chary, Neelesh Kumar Mehra
ACS Applied Bio Materials (2025) Vol. 8, Iss. 3, pp. 1749-1784
Closed Access
Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research
Nauf Bou Antoun, Hiba-Tun-Noor A. Mahmood, Anthony J. Walker, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1799-1799
Open Access
Dual targeted lipid nanoparticles for enhanced DNA delivery and transfection of breast cancer cells
Claudia Lotter, Megan Anna Stierli, Ramya Deepthi Puligilla, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025) Vol. 209, pp. 114674-114674
Open Access
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1973-1973
Open Access
Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors
Manal M. Kandeel, Mohammed K. Abdelhameid, Mohamed A. Said, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1105-1105
Open Access
Pain Signaling by GPCRs and RTKs
B. Schmidt, Francesco De Logu, Romina Nassini, et al.
Trends in Pharmacological Sciences (2025)
Closed Access
Nanotechnology in Imatinib delivery: advancing cancer treatment through innovative nanoparticles
Azam Ghadami, Sonia Fathi‐karkan, Bazla Siddiqui, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
TogoPhosTAC: A Ready-To-Go and Adaptable Targeted Protein Dephosphorylation System
Po‐Han Chen, Yu-Yu Chen, Dong-Ting Ke, et al.
Research Square (Research Square) (2025)
Closed Access
Cellular Receptor Tyrosine Kinase Signaling Plays Important Roles in SARS-CoV-2 Infection
Shania Sanchez, Brigitte Flannery, Hannah Murphy, et al.
Pathogens (2025) Vol. 14, Iss. 4, pp. 333-333
Open Access
Global analysis of actionable genomic alterations in thyroid cancer and precision-based pharmacogenomic strategies
Samantha Espinoza-Ferrao, Gabriela Echeverría‐Garcés, Sebastián Rivera-Orellana, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review
Magdalena Kędzierska, Magdalena Bańkosz
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7131-7131
Open Access | Times Cited: 1
Kallmann syndrome: Diagnostics and management
Rajiv Kumar Yadav, Baiyu Qi, Jianping Wen, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 119994-119994
Closed Access | Times Cited: 1
In Silico Drug Encapsulation Using 2-Hydroxypropyl-β-CD, Tyrosine Kinase and Tyrosinase Inhibition of Dinuclear Cu(II) Carboxylate Complexes
Amir Karim, Najeeb Ullah, Muhammad Javed Iqbal, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 134, pp. 108903-108903
Closed Access | Times Cited: 1
EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities
Lisa Toracchio, Marianna Carrabotta, Caterina Mancarella, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12191-12191
Open Access | Times Cited: 1
Mechanisms of breast cancer metastasis: the role of extracellular matrix
Rui Chen, Ranqi Zhang, Famin Ke, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Editorial: Molecular targets in oncological and hematological disease management: innovations in precision medicine
Adrian Bogdan Țigu, Gregory Wiedman, Stefan Eugen Szedlacsek
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top